Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Clinuvel Pharmaceuticals Ltd banner

Clinuvel Pharmaceuticals Ltd
F:UR9A

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
F:UR9A
Watchlist
Price: 4.56 EUR Market Closed
Market Cap: €228.6m
Write Note Create Alert Ask AI

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
What is Dividend Safety Rate?
Previous Payment
-
Today
Next Payment
-
Today
Oct 21, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-

Dividend Yield
Clinuvel Pharmaceuticals Ltd

3Y
5Y
10Y
15Y
30Y
Dividend Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Dividend Per Share
Clinuvel Pharmaceuticals Ltd

Over the past 5 Years, dividends per share for UR9A have increased by 98%.
What is dividend per share?
Dividend Streak
Growth 3Y
Growth 5Y
Growth 10Y
3Y
5Y
10Y
15Y
30Y
Ex-Dividend Date Amount Period Declaration Date Record Date Payment Date
Load More

Payout Ratio
Clinuvel Pharmaceuticals Ltd

3Y
5Y
10Y
15Y
30Y
Payout Ratio, Past 5 Years
Min
Max
Current Payout
Min Payout
Max Payout
Average Payout
Median Payout

Peers Comparison
Dividends

Shareholder Yield

Shareholder Yield
What is shareholder yield?
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Clinuvel Pharmaceuticals Ltd

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Clinuvel Pharmaceuticals Ltd

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

UR9A Price
Clinuvel Pharmaceuticals Ltd

1Y 3Y 5Y 10Y 15Y 20Y
Annual Price Range
4.56
52w Low
4.3
52w High
7.25
Price Metrics
Average Annual Return -22.97%
Standard Deviation of Annual Returns 13.01%
Max Drawdown -83%
Shares Statistics
Market Capitalization 383.8m EUR
Shares Outstanding 50 127 300
Percentage of Shares Shorted
N/A

UR9A Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about UR9A's stock splits.

Continue UR9A Research

Summary
UR9A intrinsic value, competitors valuation, and company profile.
DCF Valuation
UR9A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UR9A stock valuation using valuation multiples.
Wall St Estimates
UR9A price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UR9A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Clinuvel Pharmaceuticals Ltd listings:
OTC • USD
CLVLF
 ASX • AUD
CUV
 F • EUR
UR9
 XMUN • EUR
UR9
 SWB • EUR
UR9
 NASDAQ • USD
CUVL
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join 361,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.